- ►angrylapdog.com D Saslow, C Boetes, W Burke, S Harms, MO … - CA: A Cancer Journal for Clinicians, 2007 - Am Cancer Soc New evidence on breast Magnetic Resonance Imaging (MRI) screening has become
available since the American Cancer Society (ACS) last issued guidelines for the
early detection of breast cancer in 2003. A guideline panel has reviewed ... Cited by 304 - Related articles - BL Direct - All 30 versions
T Abdel-Fatah, DG Powe, Z Hodi, AHS Lee, JS … - The American journal of surgical pathology, 2007 - journals.lww.com Tarek MA Abdel-Fatah, MBBCh, MSc,* Desmond G. Powe, PhD,* Zsolt Hodi, MRCPath,w
Andrew HS Lee, FRCPath,w Jorge S. Reis-Filho, MD, PhD,z and Ian O. Ellis,
FRCPathw ... Abstract: This study was undertaken to determine the morpho- ... Cited by 50 - Related articles - BL Direct - All 5 versions
T Abdel-Fatah, DG Powe, Z Hodi, JS Reis-Filho … - The American Journal of Surgical Pathology, 2008 - journals.lww.com We have previously provided evidence showing an association between some
precursor lesions with low nuclear grade breast carcinomas (LNGBCs). In this
study, further immunophenotypic support to our proposed route of ... Cited by 24 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org RT Chlebowski, GL Anderson, DS Lane, AK … - JNCI Journal of the National Cancer Institute, 2007 - jnci.oxfordjournals.org Background: Strategies for estrogen receptor (ER)–positive breast cancer risk
reduction in postmenopausal women require screening of large populations to
identify those with potential benefit. We evaluated and attempted to ... Cited by 19 - Related articles - BL Direct - All 10 versions
SE Pinder, E Provenzano, JS Reis-Filho - Pathology, 2007 - Informa Pharma Science Histopathologists are encountering intra‐lobular epithelial proliferations
more frequently in core biopsies taken from lesions identified in mammographic
breast screening programmes. In particular, columnar cell lesions are ... Cited by 13 - Related articles - BL Direct - All 4 versions
- ►nih.gov M Ghofrani, B Tapia, FA Tavassoli - Virchows Archiv, 2006 - Springer Abstract To measure discrepancies in diagnoses and recommendations impacting
management of proliferative lesions of the breast, a questionnaire of five
problem scenarios was distributed among over 300 practicing pathologists. ... Cited by 13 - Related articles - BL Direct - All 6 versions
JS Lee - Virchows Archiv, 2007 - Springer Abstract Promoter hypermethylation in precursor lesions of the breast cancer may
be biomarkers of cancer risk and targets for cancer chemoprevention. Pi-class
glutathione- S-transferases (GSTP1) is inactivated by promoter hyper- ... Cited by 12 - Related articles - BL Direct - All 9 versions
SE Pinder, JS Reis-Filho - British Medical Journal, 2007 - jcp.bmj.com The term "columnar cell lesions" encompasses a spectrum of processes,
characterised by variably dilated acini, lined by one to several layers of
tightly packed, columnar-shaped epithelial cells. These lesions have ... Cited by 11 - Related articles - BL Direct - All 3 versions
L Wiechmann, HM Kuerer - CA A Cancer Journal for Clinicians - interscience.wiley.com Ductal carcinoma in situ (DCIS) accounts for approximately 20% of
mammographically detected breast cancers. DCIS can recur or progress to invasive
breast cancer, but the ability to predict the outcome of patients with DCIS ... Cited by 11 - Related articles - BL Direct - All 4 versions
L Cortesi, D Turchetti, I Marchi, A Fracca, B … - BMC cancer, 2006 - biomedcentral.com We defined different risk categories and surveillance strategies to identify
early BC in 1325 healthy women recruited by the Modena Study Group for familial
breast and ovarian cancer. Four BC risk categories included BRCA1/2 ... Cited by 8 - Related articles - Cached - All 6 versions
